Avanos MedicalAVNS +0.08%62 Operating Margin % is 4.88% as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.43 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Avanos Medical ranks worse than 53.31% on this metric.
The historical rank and industry rank for Avanos Medical's Operating Margin % or its related term are showing as below:
AVNS'
s Operating Margin % Range Over the Past 10 Years
Min: -18.92 Med: -3.19 Max: 5.89
Current: 1.96
AVNS's Operating Margin % is ranked worse than 53.31% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs AVNS: 1.96
Avanos Medical's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Avanos Medical (NYSE:AVNS) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Avanos Medical Operating Margin % Related Terms
Avanos Medical Operating Margin % Historical Data
* Premium members only.
The historical data trend for Avanos Medical's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVNS vs IRMD, TNDM, ATEC: Operating Margin % Comparison
For the Medical Devices subindustry, Avanos Medical's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Avanos Medical's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a Operating Margin % of 4.88% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Avanos Medical and its competitors. According to the industry distribution chart, Avanos Medical ranks #435 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Avanos Medical's Operating Margin % too high?
Avanos Medical's current Operating Margin % is 4.88%. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Avanos Medical's value of 4.88% is 40.8% above this industry median. Based on the distribution chart, Avanos Medical ranks #435 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Operating Margin % compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #435 out of 816 companies for Operating Margin %. This places Avanos Medical in the lower half of its industry. The industry median Operating Margin % is 3.47. Avanos Medical's value of 4.88% is 40.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current Operating Margin % of 4.88% is 40.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current Operating Margin % is 4.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.43, compared to a current price of $24.95 — trading 28.4% above its estimated fair value. The current Operating Margin % is 4.88% and 40.8% above the Medical Devices & Instruments industry median of 3.47. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Operating Margin % is 4.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.4% above its estimated GF Value™ of $19.43.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
Operating Margin %: 4.88%
GF Value™: $19.43 vs. price of $24.95 (28.4% above fair value)
Industry Position: 40.8% above the Medical Devices & Instruments median (#435 of 816)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
